Cascades (TSE:CAS – Get Free Report) was upgraded by research analysts at Scotiabank from a “hold” rating to a “strong-buy” rating in a note issued to investors on Monday,Zacks.com reports.
Several other research analysts have also recently issued reports on CAS. TD Securities raised their target price on Cascades from C$12.00 to C$14.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. CIBC increased their price objective on shares of Cascades from C$12.00 to C$13.00 in a research note on Wednesday, January 15th. Finally, Royal Bank of Canada boosted their target price on shares of Cascades from C$12.00 to C$13.00 and gave the company a “sector perform” rating in a research report on Friday, December 20th. Four equities research analysts have rated the stock with a hold rating, one has given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of C$12.50.
Get Our Latest Stock Analysis on CAS
Cascades Stock Performance
Cascades (TSE:CAS – Get Free Report) last posted its earnings results on Thursday, November 7th. The company reported C$0.27 EPS for the quarter, topping analysts’ consensus estimates of C$0.14 by C$0.13. Cascades had a negative net margin of 0.91% and a negative return on equity of 1.44%. During the same period in the prior year, the firm posted $0.44 earnings per share. As a group, equities research analysts expect that Cascades will post 1.2959309 earnings per share for the current year.
Insider Buying and Selling at Cascades
In other news, Senior Officer Luc Langevin sold 3,000 shares of the business’s stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of C$11.30, for a total value of C$33,900.00. Insiders own 23.78% of the company’s stock.
Cascades Company Profile
Cascades Inc produces, converts, and markets packaging and tissue products in Canada and the United States. The company operates through three segments: Containerboard, Specialty Products, and Tissue Papers. It offers various packaging solutions and tissue products comprised of recycled fibers; tissue papers, comprising parent rolls of virgin and recycled fibres; specialty products, including uncoated recycled boxboards; and containerboards.
Further Reading
- Five stocks we like better than Cascades
- Trading Halts Explained
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- Are Penny Stocks a Good Fit for Your Portfolio?
- What Does the Future Hold for Eli Lilly?
- Stock Splits, Do They Really Impact Investors?
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Cascades Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cascades and related companies with MarketBeat.com's FREE daily email newsletter.